当前位置: X-MOL 学术ACS Sens. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
A DNA-Based MRI Contrast Agent for Quantitative pH Measurement
ACS Sensors ( IF 8.9 ) Pub Date : 2021-02-24 , DOI: 10.1021/acssensors.1c00296
Hyewon Seo 1 , Kristine Y Ma 1 , Erin E Tuttle 2 , Isen Andrew C Calderon 1 , Alissa D Buskermolen 1 , Chris A Flask 3 , Heather A Clark 1, 2
Affiliation  

Extracellular pH is important in clinical measurements due to its correlation to cell metabolism and disease progression. In MRI, T1/T2 ratiometric analysis and other methods have been previously applied to quantify pH using conventional pulse sequences. However, for nanoparticle-based approaches, heterogeneity in size and surface functionalization tends toward qualitative rather than quantitative results. To address this limitation, we developed a novel DNA-based MRI contrast agent, pH-DMRCA, which utilizes a highly programmable and reproducible nanostructure. The pH-DMRCA is a dendritic DNA scaffold that is functionalized with a pH-responsive MRI-sensitive construct, Gd(NP-DO3A), at the end of each DNA arm. We first evaluated the r1 and r2 response of our pH-DMRCA over a range of pH values (pH = 5–9) to establish a relaxometric model of pH. These MRI-based assessments of pH were validated in a separate set of samples using a pH electrode (n = 18) and resulted in a good linear correlation (R2 = 0.99, slope = 0.98, intercept = 0). A Bland–Altman analysis of the results also showed reasonable agreement between the calculated pH and measured pH. Moreover, these pH comparisons were consistent across three different pH-DMRCA concentrations, demonstrating concentration-independence of the method. This MRI-based pH quantification methodology was further verified in human blood plasma. Given the versatility of the DNA-based nanostructures, the contrast agent has a potential to be applied to a wide variety of imaging applications where extracellular pH is important including cancer, stroke, cardiovascular disease, and other important diseases.

中文翻译:

用于定量 p​​H 测量的基于 DNA 的 MRI 造影剂

细胞外 pH 值在临床测量中很重要,因为它与细胞代谢和疾病进展有关。在 MRI 中,T 1 / T 2比率分析和其他方法以前已用于使用常规脉冲序列量化 pH 值。然而,对于基于纳米颗粒的方法,尺寸和表面功能化的异质性倾向于定性而不是定量的结果。为了解决这一限制,我们开发了一种新型的基于 DNA 的 MRI 造影剂 pH-DMRCA,它利用高度可编程和可重复的纳米结构。pH-DMRCA 是一种树突状 DNA 支架,在每个 DNA 臂的末端用 pH 响应性 MRI 敏感结构 Gd(NP-DO3A) 进行功能化。我们首先评估了r我们的 pH-DMRCA 在一系列 pH 值(pH = 5-9)上的1r 2响应,以建立 pH 的弛豫模型。这些基于 MRI 的 pH 评估在使用 pH 电极 ( n = 18) 的一组单独样品中进行了验证,并产生了良好的线性相关性 ( R 2= 0.99,斜率 = 0.98,截距 = 0)。对结果的 Bland-Altman 分析也表明计算的 pH 值和测量的 pH 值之间存在合理的一致性。此外,这些 pH 比较在三种不同的 pH-DMRCA 浓度下是一致的,表明该方法与浓度无关。这种基于 MRI 的 pH 量化方法在人血浆中得到了进一步验证。鉴于基于 DNA 的纳米结构的多功能性,造影剂有可能应用于细胞外 pH 值很重要的各种成像应用,包括癌症、中风、心血管疾病和其他重要疾病。
更新日期:2021-03-26
down
wechat
bug